Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Micropatch-assisted Delivery of Metronidazole
NCT05929794Phase 4Active, not recruiting
- Sponsor
- University of Iowa
- Start
- Feb 2024
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of metronidazole in rosacea (4 arms), sponsored by University of Iowa. Primary endpoints: Maximum serum metronidazole concentration at 120 hours, Time of maximum serum metronidazole concentration at 120 hours and 1 more. Started Feb 2024; status: active, not recruiting.
02
Drugs
metronidazole
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT05929794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05929794.